
Alexandria Phan, MD, discusses the importance of the approval of lanreotide for unresectable, well or moderately differentiated, locally advanced or metastatic GEP-NETs.

Your AI-Trained Oncology Knowledge Connection!


Published: February 17th 2015 | Updated: